» Articles » PMID: 28924171

A Network Integration Approach for Drug-target Interaction Prediction and Computational Drug Repositioning from Heterogeneous Information

Overview
Journal Nat Commun
Specialty Biology
Date 2017 Sep 20
PMID 28924171
Citations 224
Authors
Affiliations
Soon will be listed here.
Abstract

The emergence of large-scale genomic, chemical and pharmacological data provides new opportunities for drug discovery and repositioning. In this work, we develop a computational pipeline, called DTINet, to predict novel drug-target interactions from a constructed heterogeneous network, which integrates diverse drug-related information. DTINet focuses on learning a low-dimensional vector representation of features, which accurately explains the topological properties of individual nodes in the heterogeneous network, and then makes prediction based on these representations via a vector space projection scheme. DTINet achieves substantial performance improvement over other state-of-the-art methods for drug-target interaction prediction. Moreover, we experimentally validate the novel interactions between three drugs and the cyclooxygenase proteins predicted by DTINet, and demonstrate the new potential applications of these identified cyclooxygenase inhibitors in preventing inflammatory diseases. These results indicate that DTINet can provide a practically useful tool for integrating heterogeneous information to predict new drug-target interactions and repurpose existing drugs.Network-based data integration for drug-target prediction is a promising avenue for drug repositioning, but performance is wanting. Here, the authors introduce DTINet, whose performance is enhanced in the face of noisy, incomplete and high-dimensional biological data by learning low-dimensional vector representations.

Citing Articles

New strategies to enhance the efficiency and precision of drug discovery.

An Q, Huang L, Wang C, Wang D, Tu Y Front Pharmacol. 2025; 16:1550158.

PMID: 40008135 PMC: 11850385. DOI: 10.3389/fphar.2025.1550158.


MFCADTI: improving drug-target interaction prediction by integrating multiple feature through cross attention mechanism.

Quan N, Ma S, Zhao K, Bi X, Zhang L BMC Bioinformatics. 2025; 26(1):57.

PMID: 39966727 PMC: 11834641. DOI: 10.1186/s12859-025-06075-7.


ASGCL: Adaptive Sparse Mapping-based graph contrastive learning network for cancer drug response prediction.

Dong Y, Zhang Y, Qian Y, Zhao Y, Yang Z, Feng X PLoS Comput Biol. 2025; 21(1):e1012748.

PMID: 39883719 PMC: 11781687. DOI: 10.1371/journal.pcbi.1012748.


ISLRWR: A network diffusion algorithm for drug-target interactions prediction.

Sun L, Yin Z, Lu L PLoS One. 2025; 20(1):e0302281.

PMID: 39883675 PMC: 11781719. DOI: 10.1371/journal.pone.0302281.


Predicting drug and target interaction with dilated reparameterize convolution.

Deng M, Wang J, Zhao Y, Zhao Y, Cao H, Wang Z Sci Rep. 2025; 15(1):2579.

PMID: 39833385 PMC: 11747116. DOI: 10.1038/s41598-025-86918-8.


References
1.
Wu Y, Blichowski M, Daskalakis Z, Wu Z, Liu C, Cortez M . Evidence that clozapine directly interacts on the GABAB receptor. Neuroreport. 2011; 22(13):637-41. DOI: 10.1097/WNR.0b013e328349739b. View

2.
Lubran M . Hematologic side effects of drugs. Ann Clin Lab Sci. 1989; 19(2):114-21. View

3.
Kearney P, Baigent C, Godwin J, Halls H, Emberson J, Patrono C . Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006; 332(7553):1302-8. PMC: 1473048. DOI: 10.1136/bmj.332.7553.1302. View

4.
Mizutani S, Pauwels E, Stoven V, Goto S, Yamanishi Y . Relating drug-protein interaction network with drug side effects. Bioinformatics. 2012; 28(18):i522-i528. PMC: 3436810. DOI: 10.1093/bioinformatics/bts383. View

5.
Benson S, Pershadsingh H, Ho C, Chittiboyina A, Desai P, Pravenec M . Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension. 2004; 43(5):993-1002. DOI: 10.1161/01.HYP.0000123072.34629.57. View